Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
Galieni P, Troiani E, Bigazzi C, Mazzotta S, Ruggieri M, Pezzoni V, Dalsass A, Mestichelli F, Caraffa P, Travaglini F, Ferretti S, Angelini M, Angelini S, Falcioni S. Galieni P, et al. Among authors: angelini m, angelini s. Bone Marrow Transplant. 2018 Jan;53(1):91-93. doi: 10.1038/bmt.2017.206. Epub 2017 Oct 2. Bone Marrow Transplant. 2018. PMID: 28967898 No abstract available.
6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia.
Dalsass A, Mestichelli F, Ruggieri M, Gaspari P, Pezzoni V, Vagnoni D, Angelini M, Angelini S, Bigazzi C, Falcioni S, Troiani E, Alesiani F, Catarini M, Attolico I, Scortechini I, Discepoli G, Galieni P. Dalsass A, et al. Among authors: angelini m, angelini s. Eur J Haematol. 2013 Jul;91(1):10-9. doi: 10.1111/ejh.12115. Epub 2013 May 24. Eur J Haematol. 2013. PMID: 23560441
Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics.
Vagnoni D, Travaglini F, Pezzoni V, Ruggieri M, Bigazzi C, Dalsass A, Mestichelli F, Troiani E, Falcioni S, Mazzotta S, Natale A, Angelini M, Ferretti S, Angelini S, Galieni P. Vagnoni D, et al. Among authors: angelini m, angelini s. Br J Haematol. 2015 Aug;170(4):523-31. doi: 10.1111/bjh.13484. Epub 2015 May 26. Br J Haematol. 2015. PMID: 26010293 Free article.
Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major.
Santarone S, Pepe A, Meloni A, Natale A, Pistoia L, Olioso P, Papalinetti G, Cuccia L, Spasiano A, Lisi R, Di Ianni M, Bonfini T, Accorsi P, Salvadori S, Papola F, Angelini S, Di Bartolomeo P. Santarone S, et al. Among authors: angelini s. Bone Marrow Transplant. 2018 Jan;53(1):39-43. doi: 10.1038/bmt.2017.214. Epub 2017 Oct 9. Bone Marrow Transplant. 2018. PMID: 28991245
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO).
Giaccone L, Mancini G, Mordini N, Gargiulo G, De Cecco V, Angelini S, Arpinati M, Baronciani D, Bozzoli V, Bramanti S, Calore E, Cavattoni IM, Cimminiello M, Colombo AA, Facchini L, Falcioni S, Faraci M, Fedele R, Guidi S, Iori AP, Marotta S, Micò MC, Milone G, Onida F, Pastore D, Patriarca F, Pini M, Raimondi R, Rovelli A, Santarone S, Severino A, Skert C, Stanghellini MTL, Tecchio C, Vassallo E, Chiarucci M, Bruno B, Bonifazi F, Olivieri A. Giaccone L, et al. Among authors: angelini s. Bone Marrow Transplant. 2018 Jan;53(1):58-63. doi: 10.1038/bmt.2017.223. Epub 2017 Oct 30. Bone Marrow Transplant. 2018. PMID: 29084200 Free article.
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria).
Olivieri A, Mancini G, Olivieri J, Marinelli Busilacchi E, Cimminiello M, Pascale SP, Nuccorini R, Patriarca F, Corradini P, Bacigalupo A, Angelini S, Poloni A, Grillo G, Onida F, Martino M, Di Renzo N, Nagler A, Mordini N, Bruno B, Ciceri F, Bonifazi F. Olivieri A, et al. Among authors: angelini s. Bone Marrow Transplant. 2020 Nov;55(11):2077-2086. doi: 10.1038/s41409-020-0902-9. Epub 2020 Apr 24. Bone Marrow Transplant. 2020. PMID: 32332918 Clinical Trial.
Secondary oral cancer following hematopoietic cell transplantation.
Santarone S, Natale A, Angelini S, Papalinetti G, Vaddinelli D, Di Bartolomeo A, Di Bartolomeo P. Santarone S, et al. Among authors: angelini s. Bone Marrow Transplant. 2021 May;56(5):1038-1046. doi: 10.1038/s41409-020-01147-z. Epub 2020 Nov 24. Bone Marrow Transplant. 2021. PMID: 33235350
The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma.
Galieni P, Travaglini F, Vagnoni D, Ruggieri M, Caraffa P, Bigazzi C, Falcioni S, Picardi P, Mazzotta S, Troiani E, Dalsass A, Mestichelli F, Angelini M, Camaioni E, Maravalle D, Angelini S, Pezzoni V. Galieni P, et al. Among authors: angelini m, angelini s. Br J Haematol. 2021 May;193(3):542-550. doi: 10.1111/bjh.17118. Epub 2021 Apr 1. Br J Haematol. 2021. PMID: 33792026 Clinical Trial.
Tongue cancer following hematopoietic cell transplantation for Fanconi anemia.
Di Bartolomeo M, Anesi A, Pellacani A, Negrello S, Natale A, Figurelli S, Vaddinelli D, Angelini S, Chiarini L, Nocini R, Di Bartolomeo P. Di Bartolomeo M, et al. Among authors: angelini s. Clin Oral Investig. 2022 Sep;26(9):5943-5952. doi: 10.1007/s00784-022-04554-2. Epub 2022 May 28. Clin Oral Investig. 2022. PMID: 35624384 Free PMC article.
152 results